Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
British Journal of Haematology
|
April 7, 1999
B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study
C Shimazaki, T Inaba, K Shimura, et al.
International Journal of Hematology
|
January 14, 1999
Flow cytometric analysis of Thy-1 expression in myelodysplastic syndrome
T Inaba, C Shimazaki, T Sumikuma, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
April 3, 2001
[Therapy-related myeloid leukemia following platinum-based chemotherapy for ovarian cancer]
K Shimura, C Shimazaki, A Okano, et al.
Leukemia & Lymphoma
|
November 9, 2001
Early relapse after high-dose chemotherapy rescued by tumor-free autologous peripheral blood stem cells in acute lymphoblastic leukemia: importance of monitoring for WT1-mRNA quantitatively
T Sakatani, C Shimazaki, H Hirai, et al.
International Journal of Hematology
|
December 24, 1997
Flow cytometric analysis of Thy-1 expression in CD34-positive acute leukemia
T Inaba, C Shimazaki, T Sumikuma, et al.
Internal Medicine (Tokyo, Japan)
|
October 3, 2001
Clinical characteristics of B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS): comparison of CD5+ with CD5- B-LAHS
C Shimazaki, T Inaba, A Okano, et al.
Bone Marrow Transplantation
|
April 1, 1997
Serum thrombopoietin levels in patients undergoing autologous peripheral blood stem cell transplantation
C Shimazaki, T Inaba, H Uchiyama, et al.
European Journal of Haematology
|
July 1, 1997
Effects of thrombopoietin (c-mpl ligand) on growth of blast cells from patients with transient abnormal myelopoiesis and acute myeloblastic leukemia
H Hirai, C Shimazaki, N Yamagata, et al.
Cell Death and Differentiation
|
May 19, 2007
Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia
J Kuroda, S Kimura, A Strasser, et al.
Leukemia
|
March 5, 2010
Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways
T Kobayashi, J Kuroda, E Ashihara, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
British Journal of Haematology
|
April 7, 1999
B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study
C Shimazaki, T Inaba, K Shimura, et al.
International Journal of Hematology
|
January 14, 1999
Flow cytometric analysis of Thy-1 expression in myelodysplastic syndrome
T Inaba, C Shimazaki, T Sumikuma, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
April 3, 2001
[Therapy-related myeloid leukemia following platinum-based chemotherapy for ovarian cancer]
K Shimura, C Shimazaki, A Okano, et al.
Leukemia & Lymphoma
|
November 9, 2001
Early relapse after high-dose chemotherapy rescued by tumor-free autologous peripheral blood stem cells in acute lymphoblastic leukemia: importance of monitoring for WT1-mRNA quantitatively
T Sakatani, C Shimazaki, H Hirai, et al.
International Journal of Hematology
|
December 24, 1997
Flow cytometric analysis of Thy-1 expression in CD34-positive acute leukemia
T Inaba, C Shimazaki, T Sumikuma, et al.
Internal Medicine (Tokyo, Japan)
|
October 3, 2001
Clinical characteristics of B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS): comparison of CD5+ with CD5- B-LAHS
C Shimazaki, T Inaba, A Okano, et al.
Bone Marrow Transplantation
|
April 1, 1997
Serum thrombopoietin levels in patients undergoing autologous peripheral blood stem cell transplantation
C Shimazaki, T Inaba, H Uchiyama, et al.
European Journal of Haematology
|
July 1, 1997
Effects of thrombopoietin (c-mpl ligand) on growth of blast cells from patients with transient abnormal myelopoiesis and acute myeloblastic leukemia
H Hirai, C Shimazaki, N Yamagata, et al.
Cell Death and Differentiation
|
May 19, 2007
Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia
J Kuroda, S Kimura, A Strasser, et al.
Leukemia
|
March 5, 2010
Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways
T Kobayashi, J Kuroda, E Ashihara, et al.
Page
of 9